ADVANCED MOLECULAR AND EXPERIMENTAL HEMATOLOGY
Academic Year 2025/2026 - Teacher: ALESSANDRA ROMANOExpected Learning Outcomes
Acquisition of the basic knowledge necessary for the choice and use of omics for the diagnosis and attribution of the risk of progression of the main neoplastic hemopathies.
At the end of the course, students will be able to choose and develop the most suitable technological approach for understanding the pathophysiological basis of hematological neoplasms, with particular reference to multiple myeloma, non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Course Structure
Required Prerequisites
Attendance of Lessons
Attendance is highly recommended due to the interactive nature of the lessons.
Detailed Course Content
Textbook Information
| Author | Title | Publisher | Year | ISBN |
|---|---|---|---|---|
| Bosi, De Stefano, Di Raimondo, La Nasa | Manuale di malattie del Sangue | Elsevier | 2012 | 9788821432620 |
| Pier Luigi Zinzani, Sante Tura, Michele Cavo | Hematology. Pathophysiology, diagnosis and treatment | Esculapio | 2018 | 8893850834 |
Learning Assessment
Learning Assessment Procedures
Learners will be invited to create a systemic diagram to illustrate one or more strategies with which to deal with resistance to one of the cellular therapies covered by the course. There is an ongoing test with 30 multiple choice questions for the intermediate assessment of learning.
Examples of frequently asked questions and / or exercises
What are NETs (neutrophil extracellular traps)?
A. Filaments of nuclear material (DNA, histones, and chromatin fibers) released by neutrophil granulocytes after contact with a
monocyte/macrophage.
B. They are fibrillar structures released following the necrosis of basophil granulocytes that have undergone apoptosis.
C. They are extracellular fibrillar networks that allow a high concentration of antimicrobial substances to reach sites of infection.
D. They are structures formed by granulocytes and macrophages to trap and destroy microorganisms.